Wockhardt to demerge its R&D businessIllustrative image – not actual.

Wockhardt has decided to demerge its research and development business into a separate entity by 1 January 2009.

The Wockhardt board has given in-principle nod to the demerger proposal. The new research entity will house the company's new drug discovery programme and innovative new technologies being developed by its research team.

The board of directors also gave an in-principle nod to raise equity/equity-linked securities to around $200 million to expand the domestic and international operations.

Also See:

Wockhardt to set up 14 hospitals by 2009 (14-Nov-07)

← All latest storiesBack to top →